Clinical Trials Browser

Phase 3 × Withdrawn × Topotecan × Clear all

NCT04943627 2022-10-05

Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA)

Phase 3 Withdrawn

Uterine Cervical Neoplasms

NCT00334867 2013-06-28

Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma

Phase 3 Withdrawn

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral